ArticleLa Radiologia medica2026
Radiomics-based prediction of pituitary adenoma consistency: a systematic review and meta-analysis.
Article in La Radiologia medica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposePituitary adenoma consistency significantly influences surgical strategy and outcomes, yet it cannot be reliably predicted using conventional imaging. By converting images into quantitative data, radiomics can identify imaging patterns that may not be distinguishable by standard visual interpretation. This study aims to evaluate the diagnostic performance of radiomics-based MRI models for predicting pituitary adenoma consistency, to determine its potential for presurgical planning. MATERIALS AND
methodsA systematic search of PubMed, EMBASE, and Scopus was performed on 12/03/2025 following PRISMA-DTA guidelines and a pre-registered protocol (PROSPERO/CRD420251246028). Eligible studies applied radiomics and machine learning/deep learning to predict pituitary adenoma consistency. We performed random-effects meta-analyses to evaluate the area under the receiver operating characteristic (ROC) curve (AUC). A hierarchical summary ROC (HSROC) model estimated sensitivity and specificity. Risk of bias and study quality were assessed with QUADAS-2 and METRICS.
resultsFourteen studies were included. The pooled discriminative performance was good (AUC = 0.86,95% C.I. [0.76;0.92], I
conclusionsRadiomics-based MRI models demonstrate good diagnostic performance for predicting pituitary adenoma consistency and may support presurgical assessment and planning. However, substantial heterogeneity, evidence of small-study effects, and limited external validation warrant cautious interpretation of the pooled estimates and currently restrict clinical generalizability. Future studies should prioritize multicenter external validation and standardized radiomics workflows.
Indexed as
Identifiers
42758236What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.